Delivery Order SPE2DB20D3111-SPE2DB25FA9HW
- Not listed
- The Defense Logistics Agency awarded a $1,857.45 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Zilretta 32 mg vials, with an ultimate completion date of August 25, 2025. This non-set-aside competitive award is classified as a child contract, indicating it derives from a larger indefinite delivery vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location in...
- The Defense Logistics Agency awarded a $11,144.70 firm fixed price delivery order to AmerisourceBergen Drug Corp for Zilretta 32 mg vials, with an ultimate completion date of September 10, 2025. This non-set-aside contract was competitively awarded on August 19, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. Zilretta is an intra-articular injection used for pain management in osteoarthritis, representing the type of...
- The Defense Logistics Agency awarded a delivery order valued at $3,714.90 to AmerisourceBergen Drug Corp for Zilretta 32 mg vials, with an ultimate completion date of August 29, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the pharmaceutical distributor's Corporate Office location in Conshohocken, Pennsylvania. Zilretta is an intra-articular injection used for pain management in osteoarthritis, reflecting the Defense Logistics Agency's...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Zilretta 32 mg vials with a ceiling value of $9,287.25. This firm fixed-price delivery order, which is not set-aside, will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 18, 2025. Zilretta is a intra-articular corticosteroid injection used for osteoarthritis pain...
- The Defense Logistics Agency awarded a delivery order valued at $3,714.90 to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Zilretta 32 mg vials, with an ultimate completion date of October 1, 2025. This is a firm fixed-price contract with no set-aside designation, competitively awarded under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The product...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) for Zilretta 32 mg vials valued at $8,915.76 under a firm fixed-price contract structure. The award was made on August 4, 2025, with an ultimate completion date of August 25, 2025. This delivery order represents a non-set-aside competitive procurement, with performance to be completed at the contractor's corporate office location in Conshohocken, Pennsylvania. Zilretta is an intra-articular injection...
- The Defense Logistics Agency awarded a $3,714.90 delivery order to AmerisourceBergen Drug Corp for Zilretta 32 mg vials, with an ultimate completion date of August 12, 2025. This is a firm fixed price, non-set-aside contract awarded on July 22, 2025, with performance to be completed at the contractor's facility in Conshohocken, Pennsylvania. Zilretta is an intra-articular injection used for osteoarthritis pain management, indicating this procurement supports military healthcare needs for pain...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Zilretta 32 mg vials, valued at $1,485.96 with a firm fixed price structure. The contract, awarded on August 13, 2025, carries an ultimate completion date of September 4, 2025, and represents a non-set-aside competitive award. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance for this pharmaceutical supply delivery. This delivery order falls...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Zilretta 32 mg vials valued at $2,228.94 with a firm fixed price structure. This competitively awarded, non-set-aside contract is scheduled for completion by September 2, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Zilretta is an intra-articular corticosteroid injection used for pain management in joint conditions, representing part of the...
- The Defense Logistics Agency awarded a $8,915.76 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Zilretta 32 mg vials, with an ultimate completion date of August 13, 2025. This non-set-aside contract, executed from AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, represents a child delivery order under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen is a major...
- SPE2DB20D3111Indefinite Delivery Contract
- SPE2DB20D3111-SPE2DB25FA9HWDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,485.96 to AmerisourceBergen Drug Corp for Zilretta 32 mg vials, with a firm fixed price and no set-aside designation. The order, placed under a competitive award process, is scheduled for completion by September 30, 2025. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery from its corporate office location. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive $999.99 billion global pharmaceutical support vehicle valued through December 2026 that serves as a prime vendor agreement for military healthcare programs worldwide. Zilretta is an intra-articular corticosteroid injection used for osteoarthritis pain management, representing part of AmerisourceBergen's extensive portfolio of specialty medications and pharmaceutical products supplied to federal medical procurement needs. The company's federal contract awards demonstrate consistent capability in fulfilling competitive procurements across multiple therapeutic domains, including pain management, neurological treatments, diabetes medications, and vaccines for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 9/9/25 |